M. Kunecki, “Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study”, Curr. Issues Pharm. Med. Sci., vol. 35, no. 4, pp. 219–223, Dec. 2022, doi: 10.2478/cipms-2022-0038.